newsfilter
← Latest News
GlobeNewswire·

ObsEva Annual Report 2021

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland and Boston, MA – March 31, 2022 – ObsEva SA (NASDAQ:OBSV), a biopharmaceutical company developing and commercializing novel therapies to improv